Documentation Centre

Flash required
June 10, 2011
What is the prevalence of CVD risk factors among patients with type 2 diabetes, and how do these factors impact clinical management?
By Nicholas J. Wareham, MB, PhD, Director, MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK [0:42 min.] [3MB]

  • See all Expert Opinions of Nicholas J. Wareham, MB, PhD, Director, MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge, UK

Download Video


Key Words
Documentation Centre, Diabetes, Hypertension